Submission guidelines for abstract submission to the Pharmaceutical 2025:
Submission Portal: Submit your abstract through the designated online submission portal provided on the conference website.
Abstract Format: Prepare your abstract according to the specified format guidelines, including word count, font size, and formatting style.
Title: Provide a concise and descriptive title that accurately reflects the content of your research.
Authors: List all authors' names, affiliations, and contact information. Indicate the presenting author if different from the primary author.
Abstract Content: Clearly state the objectives, methods, results, and conclusions of your research within the abstract. Avoid abbreviations and undefined acronyms.
Keywords: Include a list of relevant keywords or phrases to facilitate indexing and searchability.
Clarity and Conciseness: Write your abstract in clear, concise language, avoiding unnecessary jargon or technical terms that may be unclear to readers.
Relevance: Ensure that your abstract aligns with the conference theme and focuses on topics relevant to Pharmaceutical 2025.
Graphics and Tables: If applicable, include relevant graphics, tables, or images to enhance understanding of your research findings. Ensure they are high quality and clearly labelled.
References: If citing previous research or literature, include appropriate references following the specified citation style.
Submission Deadline: Submit your abstract by the specified deadline to be considered for presentation at the conference. Late submissions may not be accepted.
Confirmation: Upon successful submission, you should receive a confirmation email or notification acknowledging your abstract.
Review Process: Abstracts will undergo a peer review process by the conference scientific committee. Notification of acceptance or rejection will be communicated within the specified timeframe.
Presentation Format: If your abstract is accepted, follow the guidelines provided for oral or poster presentation, including presentation length, formatting requirements, and session scheduling.
NOTE: Download the abstract template from the above for submission reference.
Adhering to these submission guidelines will help ensure that your abstract is properly formatted, relevant, and competitive for consideration at the Pharmaceutical 2025.
Transitioning to digital product information to ensure a sustainable future
2025-01-20 - 2025-01
Sarah Moores, Global Sustainability Director at AstraZeneca, discusses the potential scope for establishing electronic product information (ePI) in the pharmaceutical industry to support its endeavours in environmental sustainability.
The impact of the healthcare sector on the environment is no big secret, but a small change could potentially save half a million trees each year, and significantly reduce its carbon footprint.
